
AI Boosts Clinical Trial Success Rates at AstraZeneca
Artificial intelligence is helping one of the world's largest pharmaceutical companies develop better medicines faster and dramatically improve the odds that expensive clinical trials will succeed. The technology is already transforming how researchers design drugs and predict which treatments will work.
















